Respiratory Function, Exercise Capacity and Peripheral Muscle Strength Among Patients With CF, PCD and Healthy Children
- Conditions
- Primary Ciliary DyskinesiaCystic Fibrosis
- Interventions
- Other: Measurement of functional capacityOther: pulmonary function testOther: Functional capacityOther: Peripheral muscle strengthOther: Respiratory muscle strength
- Registration Number
- NCT04161313
- Lead Sponsor
- Bezmialem Vakif University
- Brief Summary
The aim of this study is to compare pulmonary function, respiratory muscle strength, exercise capacity and peripheral muscle strength of patients with CF, PCD and healthy childrens.
- Detailed Description
The impaired airway clearence and pulmonary functions, exercise intolerance, low physical activity level and decreased peripheral muscle strength make physiotherapy approaches important in the management of CF and PCD.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 76
- Diagnosis of cystic fibrosis or primary ciliary dyskinesia
- Hospitalization history in past month
- Diagnosis of other chronic pediatric diseases which may impair exercise tolerance such as cerebral palsy or neuromuscular disease
- Candidates for lung transplantation or history of lung transplantation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Cystic fibrosis Peripheral muscle strength children with cystic fibrosis Cystic fibrosis pulmonary function test children with cystic fibrosis Cystic fibrosis Functional capacity children with cystic fibrosis healthy controls Respiratory muscle strength Age-matched healthy volunteers primary ciliary dyskinesia pulmonary function test children with primary ciliary dyskinesia Cystic fibrosis Measurement of functional capacity children with cystic fibrosis primary ciliary dyskinesia Measurement of functional capacity children with primary ciliary dyskinesia healthy controls Measurement of functional capacity Age-matched healthy volunteers healthy controls Functional capacity Age-matched healthy volunteers primary ciliary dyskinesia Peripheral muscle strength children with primary ciliary dyskinesia healthy controls pulmonary function test Age-matched healthy volunteers healthy controls Peripheral muscle strength Age-matched healthy volunteers Cystic fibrosis Respiratory muscle strength children with cystic fibrosis primary ciliary dyskinesia Functional capacity children with primary ciliary dyskinesia primary ciliary dyskinesia Respiratory muscle strength children with primary ciliary dyskinesia
- Primary Outcome Measures
Name Time Method Six-minute walk test distance 15 minutes Distance walked in six minutes will be recorded in meters. Test will be conducted according to the guideline of American Thoracic Society (ATS).
- Secondary Outcome Measures
Name Time Method Forced Vital Capacity (FVC) 5 minutes FVC will be measured using basic spirometry and expressed as the percentage of the predicted value according to the guideline of European Respiratory Society (ERS)
Forced Expiratory Volume in 1 second (FEV1) 5 minutes FEV1 will be measured using basic spirometry and expressed as the percentage of the predicted value according to the guideline of European Respiratory Society (ERS)
Peak Expiratory Flow (PEF) 5 minutes PEF will be measured using basic spirometry and expressed as the percentage of the predicted value according to the guideline of European Respiratory Society (ERS)
M. Quadriceps strength 5 minutes Isometric M. Quadriceps strength (kg) will be measured using electronic hand held dynamometer in sitting position.
Trial Locations
- Locations (1)
Bezmialem Vakıf University
🇹🇷Istanbul, Turkey